Last reviewed · How we verify

NCT03939572

Effects of Physical Activity Adequacy Mindsets on Health and Wellbeing

Completed NA Last updated 30 January 2020
What this trial tests

NA trial testing Accurate step count feedback in Activity Adequacy Mindsets in 164 participants. Completed in 15 November 2019.

Timeline
30 May 2018
Primary endpoint
15 November 2019
15 November 2019

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment164
Start date30 May 2018
Primary completion15 November 2019
Estimated completion15 November 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Activity Adequacy Mindsets. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is widely known that physical activity is important for health and wellbeing, yet most Americans do not meet recommended levels of activity. People may commonly believe that only the actual amount of physical activity matters for health and wellbeing. However, the investigators propose that individuals' mindsets about the adequacy of their level of physical activity and its corresponding health consequences (activity adequacy mindsets) affect health outcomes, over and above their actual level of physical activity. In recent years, health technologies such as wearable fitness trackers have become popular tools to promote higher levels of physical activity. This study leverages the tracking and feedback capabilities of Apple Watch to study the effects of mindsets about physical activity on health and wellbeing, as well as the pathways through which these effects may occur.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of Wearable Fitness Trackers and Activity Adequacy Mindsets on Affect, Behavior, and Health: Longitudinal Randomized Controlled Trial.
    Zahrt OH, Evans K, Murnane E, Santoro E, et al · · 2023 · cited 26× · PMID 36696172 · DOI 10.2196/40529

Verify or expand the search:

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03939572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing